Human Papilloma Vaccine may be too risky for most

[Guest guest]

Gerard: Here are two more articles for the Human Papiloma Vaccine on

_www.ProgressiveConvergence.com_ (http://www.progressiveconvergence.com/) .

That is

three all to together. Please put one box on the home page and have it link

to a content page of the three articles and then those will hotlink to these

two and the one I just sent you.

 

This expose article by Cindy Bevington of KPC news documents Dr.Harpers,the

original researcher who was promoting the vaccine. Dr. Harper talks about

her negative concerns regarding the HPV vaccine, concerns that the Vaccine

manufacturers are not telling us.

_http://kpcnews.com/articles/2007/08/20/online_features/hpv_vaccine/doc4613262

8d2d8a984214059.txt _

(http://kpcnews.com/articles/2007/08/20/online_features/hpv_vaccine/doc46132628d\

2d8a984214059.txt)

The AMA Journal of American Medicine (JAMA) warns Legislators about

mandatory HPV vaccine:

_http://jama.ama-assn.org/cgi/content/full/297/17/1921

_

(http://kpcnews.com/articles/2007/08/20/online_features/hpv_vaccine/doc46132628d\

2d8a984214059.txt) _JAMA excerpt: However, the rush to make HPV

vaccination mandatory in school-aged girls presents ethical concerns and is

likely to

be counterproductive. _

(http://kpcnews.com/articles/2007/08/20/online_features/hpv_vaccine/doc46132628d\

2d8a984214059.txt)

The ACIP recommendation supports making quadrivalent vaccination the

standard of clinical care. However, it is important to emphasize that the

vaccine

is supported by limited efficacy and safety data. Clinical trials have thus

far involved a relatively small population (<12 000 participants) for a limited

period of follow-up (5 years). The vaccine has not been evaluated for

efficacy among younger girls (aged 9 to 15 years). Yet, if the vaccine were

required nationwide, it would be administered to some 2 million girls and

young

women, most of them between 11 and 12 years old and some as young as 9 years

old. The longer-term effectiveness and safety of the vaccine still need to be

evaluated among a large population, and particularly among younger girls.

Given that the overall prevalence of HPV types associated with cervical

cancer is relatively low (3.4%)_ 4_

(http://jama.ama-assn.org/cgi/content/full/297/17/1921#REF-JED70024-4) and that

the long-term effects are unknown, it is

unwise to require a young girl with a very low lifetime risk of cervical

cancer to be vaccinated without her assent and her parent's consent. Consider

the information a clinician can honestly provide to a 12-year-old girl to

obtain her assent: " The 3 injections will probably protect you from an

infection

that you can only get from sexual contact, but research has not shown how long

the protection will last or whether it might have rare bad effects on your

health. "

 

(http://kpcnews.com/articles/2007/08/20/online_features/hpv_vaccine/doc46132628d\

2d8a984214059.txt)

 

--

Warmest regards,

 

Dannemann

former director, National Coalition of Organized Women (NCOW)

_www.ProgressiveConvergence.com_ (http://www.progressiveconvergence.com/)

917 804-0786

 

 

 

************************************** Get a sneak peek of the all-new AOL at

http://discover.aol.com/memed/aolcom30tour